Literature DB >> 17633053

The biologic rationale of hyperthermia.

B Hildebrandt1, P Wust.   

Abstract

The clinical efficacy of various of hyperthermia approaches has been demonstrated in the scope of various randomised trials. In addition, a large body of preclinical data on alterations of cellular and molecular pathways under the circumstance of elevated temperatures is available. However, there is still uncertainty about the mechanisms which are acutally responsible for the beneficial effect of clinical hyperthermia when applied as an adjunt to radiotherapy, chemotherapy, or radiochemotherapy. This chapter gives a clinically orientated overview on the cytotoxic effect of heat alone and in conjunction with radiation and drugs, heat-induced alterations of the tumour microenvironment, and the immunological targets of hyperthermia.

Entities:  

Mesh:

Year:  2007        PMID: 17633053     DOI: 10.1007/978-0-387-48993-3_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  9 in total

1.  Apoptosis-inducing effects of cetuximab combined with radiotherapy and hypothermia on human nasopharyngeal carcinoma CNE cells.

Authors:  Wenqi Liu; Min Kang; Yutao Qin; Zhuxin Wei; Rensheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer.

Authors:  Eduardo G Moros; Jose Peñagaricano; Petr Novàk; William L Straube; Robert J Myerson
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

3.  Experimental Investigation of Magnetic Nanoparticle-Enhanced Microwave Hyperthermia.

Authors:  Brogan T McWilliams; Hongwang Wang; Valerie J Binns; Sergio Curto; Stefan H Bossmann; Punit Prakash
Journal:  J Funct Biomater       Date:  2017-06-22

4.  Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer.

Authors:  Chelsea M Edelblute; James Hornef; Niculina I Burcus; Thomas Norman; Stephen J Beebe; Karl Schoenbach; Richard Heller; Chunqi Jiang; Siqi Guo
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

5.  Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles.

Authors:  Antonio Cervadoro; Chiara Giverso; Rohit Pande; Subhasis Sarangi; Luigi Preziosi; Jarek Wosik; Audrius Brazdeikis; Paolo Decuzzi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

6.  The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.

Authors:  Karolin Franke; Melanie Kettering; Kathleen Lange; Werner A Kaiser; Ingrid Hilger
Journal:  Int J Nanomedicine       Date:  2013-01-20

7.  Proteomic analysis of protein expression profiles during hyperthermia-induced apoptosis in Tca8113 cells.

Authors:  Wen Jiang; Li Bian; Ning Wang; Yongwen He
Journal:  Oncol Lett       Date:  2013-05-20       Impact factor: 2.967

8.  High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area.

Authors:  Susanne Kossatz; Robert Ludwig; Heidi Dähring; Volker Ettelt; Gabriella Rimkus; Marzia Marciello; Gorka Salas; Vijay Patel; Francisco J Teran; Ingrid Hilger
Journal:  Pharm Res       Date:  2014-06-03       Impact factor: 4.200

9.  Moderate Heat Application Enhances the Efficacy of Nanosecond Pulse Stimulation for the Treatment of Squamous Cell Carcinoma.

Authors:  Chelsea M Edelblute; Siqi Guo; James Hornef; Enbo Yang; Chunqi Jiang; Karl Schoenbach; Richard Heller
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.